Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep725 | Thyroid | ECE2021

Vitamin D deficiency and Hashimoto’s thyroiditis

Roman Gimeno Sergio , Urdaniz Borque Rosana , Elena Pérez Galende , Borja Sanz Martín , Jose Jorge Ortez Toro

IntroductionThe main role of vitamin D is regulating bone metabolism, but over the past years, the importance of vitamin D in non-skeletal actions has been studied. Vitamin D deficiency is very common in our environment. This deficit has been associated with higher risk of many chronic diseases, such as osteoporosis, hypertension, diabetes and even obesity. Recent evidence has demonstrated an association between low vitamin D status and autoimmune thyroi...

ea0073ep193 | Thyroid | ECE2021

Depression among patients with autoimmune thyroiditis

Roman Gimeno Sergio , Urdaniz Borque Rosana , Elena Pérez Galende , Borja Sanz Martín , Jose Jorge Ortez Toro

IntroductionToday, it is well recognized that disturbances in thyroid function may significantly affect mental status including emotion and cognition. Several studies have demonstrated the existence of a relationship between depression and hypothyroidism, although there is still no clear explanation of the pathophysiology that causes this association.ObjectivesTo assess whether there is a higher prevalence of...

ea0070aep520 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Short and long-term glycemic variability associated with severe hypoglycemia and retinopathy in type 1 diabetes mellitus

Sanz Martín Borja , Roman Gimeno Sergio , Miguel Peteiro Miranda Carlos , Jorge Ortez Toro Jose , Agudo Ana , Urdaniz Rosana , Antonio Gimeno Orna José

Introduction: Severe hypoglycemia and retinopathy are two of the main complications of diabetes mellitus (DM). Traditionally, glycosylated hemoglobin (or A1C) has been used as the gold standard measurement of glycemic control; however, there is a significant percentage of complications riskassociated with the evolution of diabetes that is not fully explained by this single marker. Short and long-term glycemic variability has been postulated as one of the main variables that co...

ea0070ep205 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Influence of the time gap between appointments on type 1 Diabetes Mellitus patients’ control

Roman Gimeno Sergio , Ortez Toro Jose Jorge , Peteiro Miranda Carlos Miguel , Sanz Martín Borja , Urdaniz Rosana , García García Blanca , Gimeno Orna José Antonio

Introduction: One of the often-discussed topics in the management guidelines for Type 1 Diabetes Mellitus (T1DM) is the ideal time gap that should exist between patient check-ups. A period of three to six months is usually recommended, which sometimes is difficult to achieve due to the high number of patients. But to what extent does the time gap between appointments in the follow-up of T1DM patients affect their diabetes’ control?Objectives: To kn...

ea0073aep778 | Thyroid | ECE2021

Thyroid nodule classified as Bethesda III: Our clinical experience and management strategy

Borja Sanz Martín , Roman Gimeno Sergio , Elena Pérez Galende , Sota Ochoa Patricia , Carlos Miguel Peteiro Miranda , Jose Jorge Ortez Toro , Urdaniz Borque Rosana

BackgroundThe prevalence of malignancy among Bethesda category III (atypia of undetermined significance) cytologies is variable in different studies.ObjectiveThe aim of this paper is to evaluate the risk of malignancy of thyroid nodules classified as Bethesda III in our hospital.MethodsWe have reviewed the medical records of 146 patients who underwent FNA with Bet...

ea0070aep890 | Thyroid | ECE2020

New predictors of response to treatment with intravenous methylprednisolone in thyroid-associated orbitopathy

Roman Gimeno Sergio , Jorge Ortez Toro Jose , Miguel Peteiro Miranda Carlos , Sanz Martín Borja , Urdaniz Rosana , Agudo Ana , Borau Laura , Campos Fernández Julia , Aguillo Gutierrez Esperanza

Introduction: Thyroid-associated ophthalmopathy is the most frequent extrathyroidal manifestation of Graves’ disease. Its treatment is based on the administration of intravenous corticosteroids, and the clinical activity score (CAS), TSH-binding inhibitor immunoglobulin (TBII) and TSH-receptor antibodies (TRAb) have been classically used to measure the response to treatment. However, in recent studies [1] it has been observed that other analytical parameters such as chol...